Live webinar on How to Prepare for FDA BIMO Inspections May 2, 2012

This webinar is intended to provide practical and actionable guidance on how to proactively prepare for a sustainable FDA Bioresearch Monitoring (BIMO) inspection and the proper response, if necessary, during and after the inspection including Do’s and Don’ts.



The United States Food and Drug Administration (FDA) regulates scientific studies, which are designed to develop evidence to support the safety and effectiveness of investigational drugs, biological products and medical devices including in vitro diagnostic devices. Those who are involved in carrying out preclinical studies and clinical studies must comply with the relevant and applicable statutes and regulations, which covers GLP and GCP.

Official Website: https://compliance2go.com/index.php?option=com_training&speakerkey=27&productKey=111